Sign up to save your podcasts
Or
Share Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
View all episodes
By American Academy of Neurology
4.8
132132 ratings
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
More shows like Neurology Minute
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
299 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,347 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
188 Listeners
Continuum Audio
80 Listeners